Is DOTS-plus a feasible and cost-effective strategy?

Garner, Paul ORCID: 0000-0002-0607-6941, Alejandria, Marissa and Lansang, Mary Ann ORCID: 0000-0002-6606-0466
(2006) Is DOTS-plus a feasible and cost-effective strategy? PLoS medicine, 3 (9). e350-.

[img] PDF
838.pdf - Unspecified
Available under License Creative Commons Attribution.

Download (191kB)


Paul Garner and colleagues discuss the implications of the pilot study by Katherine Floyd and colleagues of the DOTS-Plus project for tuberculosis control in the Philippines.

Item Type: Article
Additional Information: Published: September 12, 2006. Citation: Garner P, Alejandria M, Lansang MA (2006) Is DOTS-Plus a Feasible and Cost-Effective Strategy? PLoS Med 3(9): e350 doi:10.1371/journal.pmed.0030350
Uncontrolled Keywords: Humans, Tuberculosis, Multidrug-Resistant, Directly Observed Therapy, Feasibility Studies, Cost-Benefit Analysis, World Health Organization
Subjects: ?? R1 ??
Divisions: Faculty of Health and Life Sciences
Depositing User: Symplectic Admin
Date Deposited: 24 Jul 2008 15:44
Last Modified: 16 Mar 2024 13:32
DOI: 10.1371/journal.pmed.0030350
Publisher's Statement : Copyright: © 2006 Garner et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related URLs: